Lien Chia En News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lien chia en. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lien Chia En Today - Breaking & Trending Today
Phase 2 clinical trial results of the Medigen Vaccine Biologics Corp’s COVID-19 vaccine on Wednesday were published on the Web site of <i>The Lancet: Respiratory Medicine</i>, in an early preview before publication. The study paves the way for other nations to issue emergency use authorizations or produce the Medigen vaccine, given <i>The Lancet’s</i> credibility as a highly respected medical journal with a rigorous peer-review process, Medigen’s international affairs director Lien Chia-en (連加恩) said. Lien said that the study is important as it proposes methods for converting international units for efficacy comparisons. The methods have been used for correlating the efficacy of hepatitis B ....
By Yang Yuan-ting, Chiu Chih-jou and Jonathan Chin / Staff reporters, with staff writerPhase 2 clinical trial results of the Medigen Vaccine Biologics Corp’s COVID-19 vaccine on Wednesday were published on the Web site of The Lancet: Respiratory Medicine, in an early preview before publication. ....
Medigen Vaccine Biologics Corp (高端疫苗) yesterday reported positive results from an interim analysis of phase 2 trials for its COVID-19 vaccine, saying that the vaccine demonstrated high seroconversion rates and geometric mean titer (GMT) figures. A seroconversion rate is the percentage of participants in a trial displaying virus-specific immune memory after being given a vaccine, while the GMT measures the level of neutralizing antibody response, Medigen said. The experimental vaccine has a seroconversion rate of 99.8 percent and its GMT was 662 among the participants aged 20 to 89, while the gauges rose to 99.9 percent and 733 respectively in participants aged ....